Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
4 pending office actions • 2 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 7 patents granted in the last 365 days
The University of Oregon currently has 4 pending office actions in the Chemistry & Materials technology area. These actions are distributed across 2 distinct art units, indicating that the university's research in this field spans multiple specialized sub-disciplines. The prosecution involves 4 distinct examiners, suggesting that each pending matter is being evaluated by a different individual. This diversity in examination requires a coordinated effort to maintain consistency in the university's patenting strategy.
LIANG, SHIBIN is the busiest examiner, managing 1 pending office action. Because the busiest examiner pending count is only a portion of the 4 total pending actions, the university's prosecution environment is quite diverse. Legal representatives must navigate the specific preferences of 4 different examiners while maintaining a consistent strategy across the 2 art units involved in the Chemistry & Materials sector. This decentralized structure means that the university's success in this field is distributed across multiple points of review at the patent office.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (25%) |
| Multi-statute (no §101) | 3 (75%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LIANG, SHIBIN | 1 | 62.8% | +17.0% |
| TRAN, VIVIAN AILINH | 1 | 55.2% | +43.0% |
| YOO, SUN JAE | 1 | 71.1% | +0.3% |
| YOUNG, BRIAN ELLIS | 1 | 65.8% | +24.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19066796 | ROTATABLE PRINTHEAD FOR ELECTROHYDRODYNAMIC PROCESSES | LIANG, SHIBIN | — |
| 18622144 | PERGOLIDE TREATMENT OF OCULAR CHEMICAL INJURY | YOO, SUN JAE | — |
| 18239043 | Targeted Enrichment of Nucleic Acid Sequences | YOUNG, BRIAN ELLIS | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18653828 | ANION SENSING USING 1,2,3-TRIAZOLATE METAL-ORGANIC FRAMEWORK NANOPARTICLES | TRAN, VIVIAN AILINH | 23d overdue |
| 19066796 | ROTATABLE PRINTHEAD FOR ELECTROHYDRODYNAMIC PROCESSES | LIANG, SHIBIN | — |
| 18239043 | Targeted Enrichment of Nucleic Acid Sequences | YOUNG, BRIAN ELLIS | — |
| Art Unit | Apps |
|---|---|
| 1794 | 1 |
| 1621 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19066796 | ROTATABLE PRINTHEAD FOR ELECTROHYDRODYNAMIC PROCESSES | LIANG, SHIBIN | — | §102§103 | Non-Final OA | — | Pending | Feb 28, 2025 |
| 18653828 | ANION SENSING USING 1,2,3-TRIAZOLATE METAL-ORGANIC FRAMEWORK NANOPARTICLES | TRAN, VIVIAN AILINH | 1794 | §103 | Non-Final OA | 23d overdue | Pending | May 02, 2024 |
| 18622144 | PERGOLIDE TREATMENT OF OCULAR CHEMICAL INJURY | YOO, SUN JAE | 1621 | §102§103 | Non-Final OA | — | Pending | Mar 29, 2024 |
| 18239043 | Targeted Enrichment of Nucleic Acid Sequences | YOUNG, BRIAN ELLIS | — | §103§112 | Non-Final OA | — | Pending | Aug 28, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial